Article
Acute Myeloid Leukemia Subtype-Specific Prognostic Value of NGS in the Setting of Intensive Chemotherapy.
American journal of hematology - 1 Oct 2026
Bolarinwa Abiola, Al-Kali Aref, Alkhateeb Hassan B, Mangaonkar Abhishek A, Saliba Antoine N, Torghabeh Mehrdad Hefazi, Matin Aasiya, Elliott Michelle A, Litzow Mark R, Hogan William J, Shah Mithun V, Patnaik Mrinal M, Pardanani Animesh, Foran James M, Badar Talha, Murthy Hermant S, Punwani Nathan, Palmer Jeanne M, Sproat Lisa Z, Chen Dong, Reichard Kaaren K, He Rong, Viswanatha David S, Zepeda-Mendoza Cinthya J, Gangat Naseema, Begna Kebede H, Tefferi Ayalew
Abstract excerpt
We examined the prognostic value of routine NGS data in newly diagnosed acute myeloid leukemia (AML) treated with intensive (7 + 3 backbone) induction, specified by AML subtype. A contemporary (2015-2025) series of 545 Mayo Clinic patients (median age 56 years, females 44%) was considered. Median follow-up was 49 months with 341 (63%) allogeneic hematopoietic stem cell transplantations (AHSCT) recorded. AML...
Read the complete abstract on PubMedTopics
- Humans
- Female
- Leukemia, Myeloid, Acute
